Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML

Jacqueline Cloos; Gerrit Jansen; James A. Whitlock; Stephen P. Hunger; Johan van Meerloo; Sonja Zweegman; Terzah M. Horton; Gaye Jenkins; Xiaomin Lu; Gertjan J.L. Kaspers; Denise Niewerth

doi:https://doi.org/10.1158/1538-7445.am2014-lb-169

Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML

Jacqueline Cloos, Gerrit Jansen, James A. Whitlock, Stephen P. Hunger, Johan van Meerloo, Sonja Zweegman, Terzah M. Horton, Gaye Jenkins, Xiaomin Lu, Gertjan J.L. Kaspers, Denise Niewerth

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	LB-169-LB-169
Journal	Cancer research
Volume	74
Issue number	19 Supplement
DOIs	https://doi.org/10.1158/1538-7445.am2014-lb-169
Publication status	Published - 1 May 2015

Access to Document

https://doi.org/10.1158/1538-7445.am2014-lb-169

http://www.mendeley.com/research/abstract-lb169-ratios-immunoproteasome-constitutive-proteasome-expression-indicator-sensitivity-bort

Cite this

Cloos, J., Jansen, G., Whitlock, J. A., Hunger, S. P., Meerloo, J. V., Zweegman, S., Horton, T. M., Jenkins, G., Lu, X., Kaspers, G. J. L., & Niewerth, D. (2015). Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML. Cancer research, 74(19 Supplement), LB-169-LB-169. https://doi.org/10.1158/1538-7445.am2014-lb-169

@article{262117bb01c543eaa56329b01c659558,

title = "Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML",

author = "Jacqueline Cloos and Gerrit Jansen and Whitlock, {James A.} and Hunger, {Stephen P.} and Meerloo, {Johan van} and Sonja Zweegman and Horton, {Terzah M.} and Gaye Jenkins and Xiaomin Lu and Kaspers, {Gertjan J.L.} and Denise Niewerth",

year = "2015",

month = may,

day = "1",

doi = "https://doi.org/10.1158/1538-7445.am2014-lb-169",

language = "English",

volume = "74",

pages = "LB--169--LB--169",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "19 Supplement",

}

Cloos, J , Jansen, G, Whitlock, JA, Hunger, SP, Meerloo, JV, Zweegman, S, Horton, TM, Jenkins, G, Lu, X, Kaspers, GJL & Niewerth, D 2015, 'Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML', Cancer research, vol. 74, no. 19 Supplement, pp. LB-169-LB-169. https://doi.org/10.1158/1538-7445.am2014-lb-169

Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML. / Cloos, Jacqueline ; Jansen, Gerrit; Whitlock, James A. et al.
In: Cancer research, Vol. 74, No. 19 Supplement, 01.05.2015, p. LB-169-LB-169.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML

AU - Cloos, Jacqueline

AU - Jansen, Gerrit

AU - Whitlock, James A.

AU - Hunger, Stephen P.

AU - Meerloo, Johan van

AU - Zweegman, Sonja

AU - Horton, Terzah M.

AU - Jenkins, Gaye

AU - Lu, Xiaomin

AU - Kaspers, Gertjan J.L.

AU - Niewerth, Denise

PY - 2015/5/1

Y1 - 2015/5/1

U2 - https://doi.org/10.1158/1538-7445.am2014-lb-169

DO - https://doi.org/10.1158/1538-7445.am2014-lb-169

M3 - Article

SN - 0008-5472

VL - 74

SP - LB-169-LB-169

JO - Cancer research

JF - Cancer research

IS - 19 Supplement

ER -

Cloos J , Jansen G, Whitlock JA, Hunger SP, Meerloo JV, Zweegman S et al. Abstract LB-169: Ratios of immunoproteasome over constitutive proteasome expression are an indicator for sensitivity to bortezomib-containing reinduction chemotherapy in pediatric relapsed ALL and AML. Cancer research. 2015 May 1;74(19 Supplement):LB-169-LB-169. doi: https://doi.org/10.1158/1538-7445.am2014-lb-169